Invention Grant
- Patent Title: Six-gene biomarker of survival and response to platinum based chemotherapy in serious ovarian cancer patients
-
Application No.: US15339109Application Date: 2016-10-31
-
Publication No.: US10167516B2Publication Date: 2019-01-01
- Inventor: Christina Kendziorski Newton , Kevin Hasegawa Eng , Janet S. Rader , William H. Bradley
- Applicant: Wisconsin Alumni Research Foundation , The Medical College of Wisconsin, Inc.
- Applicant Address: US WI Madison
- Assignee: Wisconsin Alumni Research Foundation
- Current Assignee: Wisconsin Alumni Research Foundation
- Current Assignee Address: US WI Madison
- Agency: Quarles & Brady LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6886 ; G01N33/574 ; A61K31/138 ; A61K31/337 ; A61K31/4745 ; A61K31/519 ; A61K31/704 ; A61K31/7068 ; A61K33/24 ; A61K39/395

Abstract:
Described herein are methods of predicting the risk of developing ovarian cancer recurrence of a subject comprising the steps of detecting the expression levels of at least four of the six genes selected from the group consisting of AKT2, KRAS, RAC1, CALM3, RPS6KA2 and YWHAB or the gene products thereof, wherein the presence of increased expression levels of the genes or the gene products is predictive of the increased risk of developing ovarian cancer recurrence in the subject. Kits for practicing the methods are also disclosed.
Public/Granted literature
Information query